FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2327256708> ?p ?o ?g. }

• W2327256708 endingPage "128" @default.
• W2327256708 startingPage "115" @default.
• W2327256708 abstract "Canagliflozin, a sodium-glucose co-transporter 2 inhibitor, approved for the treatment of type-2 diabetes mellitus (T2DM), is metabolized by uridine diphosphate-glucuronosyltransferases (UGT) 1A9 and UGT2B4, and is a substrate of P-glycoprotein (P-gp). Canagliflozin exposures may be affected by coadministration of drugs that induce (e.g., rifampin for UGT) or inhibit (e.g. probenecid for UGT; cyclosporine A for P-gp) these pathways. The primary objective of these three independent studies (single-center, open-label, fixed-sequence) was to evaluate the effects of rifampin (study 1), probenecid (study 2), and cyclosporine A (study 3) on the pharmacokinetics of canagliflozin in healthy participants.Participants received; in study 1: canagliflozin 300 mg (days 1 and 10), rifampin 600 mg (days 4-12); study 2: canagliflozin 300 mg (days 1-17), probenecid 500 mg twice daily (days 15-17); and study 3: canagliflozin 300 mg (days 1-8), cyclosporine A 400 mg (day 8). Pharmacokinetics were assessed at prespecified intervals on days 1 and 10 (study 1); on days 14 and 17 (study 2), and on days 2-8 (study 3).Rifampin decreased the maximum plasma canagliflozin concentration (Cmax) by 28% and its area under the curve (AUC) by 51%. Probenecid increased the Cmax by 13% and the AUC by 21%. Cyclosporine A increased the AUC by 23% but did not affect the Cmax.Coadministration of canagliflozin with rifampin, probenecid, and cyclosporine A was well-tolerated. No clinically meaningful interactions were observed for probenecid or cyclosporine A, while rifampin coadministration modestly reduced canagliflozin plasma concentrations and could necessitate an appropriate monitoring of glycemic control." @default.
• W2327256708 created "2016-06-24" @default.
• W2327256708 creator A5018871095 @default.
• W2327256708 creator A5027581435 @default.
• W2327256708 creator A5036621224 @default.
• W2327256708 creator A5041412117 @default.
• W2327256708 creator A5047898874 @default.
• W2327256708 creator A5069149988 @default.
• W2327256708 creator A5076233215 @default.
• W2327256708 creator A5079135461 @default.
• W2327256708 creator A5080507363 @default.
• W2327256708 creator A5081074918 @default.
• W2327256708 creator A5082642164 @default.
• W2327256708 creator A5083478319 @default.
• W2327256708 date "2015-02-01" @default.
• W2327256708 modified "2023-09-26" @default.
• W2327256708 title "Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants" @default.
• W2327256708 cites W1541445728 @default.
• W2327256708 cites W1606165384 @default.
• W2327256708 cites W1812411003 @default.
• W2327256708 cites W1831886570 @default.
• W2327256708 cites W1974115114 @default.
• W2327256708 cites W1976696095 @default.
• W2327256708 cites W1983085727 @default.
• W2327256708 cites W1997018189 @default.
• W2327256708 cites W2003014922 @default.
• W2327256708 cites W2011163792 @default.
• W2327256708 cites W2021484546 @default.
• W2327256708 cites W2022545732 @default.
• W2327256708 cites W2024878386 @default.
• W2327256708 cites W2046877602 @default.
• W2327256708 cites W2070715790 @default.
• W2327256708 cites W2074989651 @default.
• W2327256708 cites W2076052958 @default.
• W2327256708 cites W2082627462 @default.
• W2327256708 cites W2084511068 @default.
• W2327256708 cites W2089139552 @default.
• W2327256708 cites W2090563376 @default.
• W2327256708 cites W2102437668 @default.
• W2327256708 cites W2108230265 @default.
• W2327256708 cites W2120919346 @default.
• W2327256708 cites W2125028944 @default.
• W2327256708 cites W2125748363 @default.
• W2327256708 cites W2127955110 @default.
• W2327256708 cites W2131135469 @default.
• W2327256708 cites W2143329545 @default.
• W2327256708 cites W2143764289 @default.
• W2327256708 cites W2145766137 @default.
• W2327256708 cites W2155775136 @default.
• W2327256708 cites W2167984652 @default.
• W2327256708 cites W2168926920 @default.
• W2327256708 cites W2169506468 @default.
• W2327256708 cites W2172193326 @default.
• W2327256708 cites W2181906321 @default.
• W2327256708 cites W2326010624 @default.
• W2327256708 cites W2338756568 @default.
• W2327256708 cites W57620538 @default.
• W2327256708 doi "https://doi.org/10.5414/cp202158" @default.
• W2327256708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4558628" @default.
• W2327256708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25407255" @default.
• W2327256708 hasPublicationYear "2015" @default.
• W2327256708 type Work @default.
• W2327256708 sameAs 2327256708 @default.
• W2327256708 citedByCount "34" @default.
• W2327256708 countsByYear W23272567082015 @default.
• W2327256708 countsByYear W23272567082016 @default.
• W2327256708 countsByYear W23272567082017 @default.
• W2327256708 countsByYear W23272567082018 @default.
• W2327256708 countsByYear W23272567082019 @default.
• W2327256708 countsByYear W23272567082020 @default.
• W2327256708 countsByYear W23272567082021 @default.
• W2327256708 countsByYear W23272567082022 @default.
• W2327256708 countsByYear W23272567082023 @default.
• W2327256708 crossrefType "journal-article" @default.
• W2327256708 hasAuthorship W2327256708A5018871095 @default.
• W2327256708 hasAuthorship W2327256708A5027581435 @default.
• W2327256708 hasAuthorship W2327256708A5036621224 @default.
• W2327256708 hasAuthorship W2327256708A5041412117 @default.
• W2327256708 hasAuthorship W2327256708A5047898874 @default.
• W2327256708 hasAuthorship W2327256708A5069149988 @default.
• W2327256708 hasAuthorship W2327256708A5076233215 @default.
• W2327256708 hasAuthorship W2327256708A5079135461 @default.
• W2327256708 hasAuthorship W2327256708A5080507363 @default.
• W2327256708 hasAuthorship W2327256708A5081074918 @default.
• W2327256708 hasAuthorship W2327256708A5082642164 @default.
• W2327256708 hasAuthorship W2327256708A5083478319 @default.
• W2327256708 hasBestOaLocation W23272567082 @default.
• W2327256708 hasConcept C112705442 @default.
• W2327256708 hasConcept C134018914 @default.
• W2327256708 hasConcept C185592680 @default.
• W2327256708 hasConcept C22979827 @default.
• W2327256708 hasConcept C2776769776 @default.
• W2327256708 hasConcept C2777180221 @default.
• W2327256708 hasConcept C2777451236 @default.
• W2327256708 hasConcept C555293320 @default.
• W2327256708 hasConcept C71924100 @default.
• W2327256708 hasConcept C97320921 @default.
• W2327256708 hasConcept C98274493 @default.

• next